The impact of gender and estrogen on striatal dopaminergic neurotoxicity

Annals of the New York Academy of Sciences

Volumn 844, Issue , 1998, Pages 153-165

  Miller, Diane B ^a   Ali, Syed F ^b   O'Callaghan, James P ^a   Laws, Susan C ^c  

^a Toxiology and Molecular Biology Branch   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; ESTROGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMOVANILLIC ACID; METHAMPHETAMINE; STEROID HORMONE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; ESTROGEN THERAPY; FEMALE; GENDER; HORMONE SUBSTITUTION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OVARIECTOMY; REPRODUCTION; SEX DIFFERENCE;

ANIMALIA;

EID: 0031868194     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb08230.x     Document Type: Conference Paper

References (36)

1. ASHCROFT, G. S., J. DODSWORTH, E. J. VAN BOXTEL, R. W. TARNUZZER, M. A. HORAN, G. S. SCHULTZ & M. W. J. FERGUSON. 1997. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nature Med. 3: 1209-1215.
2. DLUZEN, D. E., J. L. MCDERMOTT & B. LIU. 1996. Estrogen alters MPTP-induced neuro-toxicity in female mice: Effects on striatal dopamine concentrations and release. J. Neurochem. 66: 658-666.
3. DLUZEN, D. E., J. L. MCDERMOTT & B. LIU. 1996. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/BL mice. Neurotoxicol. Teratol. 18: 603-606.
4. GRAY, L. E., W. R. KELCE, T. WIESE, R. TYL, K. I. GAIDO, J. COOK, G. KLINEFELTER, D. DESAULNIERS, E. WILSON, T. ZACHAREWSKI, C. WALLER, P. FOSTER, J. LASKEY, J. REEL, J. GIESY, S. LAWS, J. MCLACHLAN, W. BRESLIN, R. COOPER, R. DI GIULIO, R. JOHNSON, R. PURDY, E. MILHAICH, S. SAFE, C. SONNENSCHEIN, W. WELSHONS, R. MILLER, S. MCMASTER & T. COLBORN. 1997. Endocrine screening methods workshop report: Detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod. Toxicol. 11: 719-750.
5. SOTO, A. M., C. SONNENSCHEIN, K. L. CHUNG, M. F. FERNANDEZ, N. OLEA & F. O. SERRANO. 1995. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ. Health Perspect. 103(Suppl 7): 113-122.
6. FARHAT, M. Y., M. C. LAVIGNE & P. W. RAMWELL. 1996. The vascular protective effects of estrogen. FASEB J. 10: 615-624.
7. GUSTAFSSON, J-A. 1997. Estrogen receptor β - Getting in on the Action? Nature Med. 3: 493-494.
8. IAFRATI, M. D., R. H. KARAS, M. ARONOVITZ, S. KIM, T. R. SULLIVAN, JR., D. B. LUBAHN, T. F. O'DONNELL, JR., K. S. KORACH & M. E. MENDELSOHN. 1997. Estrogen inhibits the vascular injury response in estrogen receptor a-deficient mice. Nature Med. 3: 545-548.
9. CUR, R. C., P. D. MOZLEY, S. M. RESNICK, G. L. GOTTLIEB, M. KOHN, R. ZIMMERMAN, G. HERMAN, S. ATLAS, R. GROSSMAN, D. BERRETTA, R ERWIN & R. E. GUR. 1991. Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. Proc. Natl. Acad. Sci. USA 88: 2845-2849.
10. DIAMOND, S. G., C. H. MARKHAM, M. M. HOEHN, F. H. MCDOWELL & M. D. MUENTER. 1990. An examination of male-female differences in progression and mortality of Parkinson's disease. Neurology 40: 763-766.
11. MARDER, K., M. X. TANG, H. MEJIA, B. ALFARO, L. COTE, E. LOUIS, J. GROVES & R. MAYEUX. 1996. Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology 47: 155-160.
12. CHAN, R. S., E. D. HUEY, H. L. MAECKER, K. M. COROPASSI, S. A. HOWARD, A. M. IYER, L. J. MCINTOSH, O. A. AJILORE, S. M. BROOKE & R. M. SAPOLSKY. 1996. Endocrine modulators of necrotic neuron death. Brain Pathol. 6: 481-491.
13. GOODMAN, Y., A. J. BRUCE, B. CHENG & M. P. MATTSON. 1996. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66: 1836-1844.
14. REGAN, R. F. & Y. GUO. 1997. Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia and excitatory amino acids in murine cortical cultures. Brain Res. 764: 133-140.
15. SINGER, C. A., K. L. ROGERS, T. M. STRICKLAND & D. M. DORSA. 1996. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212: 13-16.
16. BECKER, J. B. 1990. Direct effect of 17β-estradiol on striatum: Sex differences in dopamine release. Synapse 5: 157-164.
17. DI PAOLO, T., C. ROUILLARD & P. BEDARD. 1985. 17β-estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur. J. Pharmacol., 117: 197-203.
18. O'CALLAGHAN, J. P., D. B. MILLER & J. F. REINHARD, JR. 1990. Characterization of the astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Res. 521: 73-80.
19. CALABRESE, E. J. 1986. Editorial: Sex differences in susceptibility to toxic industrial chemicals. Br. J. Indust. Med. 43: 577-579.
20. O'CALLAGHAN, J. P. 1991. Quantification of glial fibrillary acidic protein: Comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 13: 275-281.
21. ALI, S. F., S. N. DAVID & G. D. NEWPORT. 1993. Age-related susceptibility to MPTP-induced neurotoxicity in mice. Neurotoxicology. 14: 29-34.
22. O'CALLAGHAN, J. P. & D. B. MILLER. 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270: 741-751.
23. SMITH, P. K., R. I. KROHN, G. T. HERMANSON, A. K. MALLIA, F. H. GARTNER, M. D. PROVENZANO, E. K. FUJIMOTO, B. J. OLSON & D. C. KLENK. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
24. NAOI, M., T. TAKAHASI & T. NAGATSU. 1987. A fluorometric determination of N-methyl-4-phenylpyridinium ion, using high-performance liquid chromatography. Anal. Biochem. 162: 540-545.
25. SAS Institute, Inc. 1996. SAS User's Guide: Statistics. SAS Institute Inc. Cary, NC.
26. O'CALLAGHAN, J. P. & D. B. MILLER. 1991. The concentration of glial fibrillary acidic protein increases with age in the mouse and rat brain. Neurobiol. Aging 12: 171-174.
27. MCEWEN, B. S. 1991. Non-genomic and genomic effects of steroids on neural activity. TIPS 12: 141-147.
28. PFAFF, D & M. KEINER. 1973. Atlas of estradiol-concentrating cells in the central nervous system of the rat. Comp. Neurol. 151: 121-158.
29. KUIPER, G. G., E. ENMARK, M. PELTO-HUIKKO, G. NILSSON & J. GUSTAFSSON. 1996. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93: 5925-5930.
30. KUIPER, G. G. J. M., B. CARLSSON, K. GRANDIEN, E. ENMARK, J. HAGGBLAD, S. NILSSON & J-A. GUSTAFSSON. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138: 863-870.
31. ZHOU, Y., J. J. WATTERS & D. M. DORSA. 1996. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137: 2163-2166.
32. MCDERMOTT, J. L., B. LIU & D. E. DLUZEN. 1994. Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp. Neurol. 125: 306-311.
33. BEHL, C., T. SKUTELLA, F. LEZOUALC'H, A. POST, M. WIDMANN, C. J. NEWTON & F. HOLSBOER. 1997. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol. Pharmacol. 51: 535-541.
34. KUPERMAN, D. I., T. E. FREYALDENHOVEN, L. SCHMUED & S. F. ALI. 1997. Methamphetamine-induced hyperthermia in mice: Examination of dopamine depletion and heat-shock protein induction. Brain Res. 17: 29-53.
35. ROOF, R. L., R. DUVDEVANI, J. W. HEYBURN & D. G. STEIN. 1996. Progesterone rapidly decreases brain edema: Treatment delayed up to 24 hrs is still effective. Exp. Neurol. 138: 246-251.
36. FREYALDENHOVEN, T. E., J. L. CADET & S. F. ALI. 1996. The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent. Brain Res. 735: 232-238.